Galectin-3 is related to right ventricular dysfunction in heart failure patients with reduced ejection fraction and may affect exercise capacity

• Published in: Scientific reports Vol. 10; no. 1; p. 16682
• Main Authors: Zaborska, Beata, Sygitowicz, Grażyna, Smarż, Krzysztof, Pilichowska-Paszkiet, Ewa, Budaj, Andrzej
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 07.10.2020
• Subjects: 692/4019; 692/53; Aged; Blood Pressure - physiology; Exercise Test; Exercise Tolerance - physiology; Female; Galectin 3 - blood; Heart Failure - blood; Heart Failure - complications; Heart Failure - physiopathology; Heart Rate - physiology; Humanities and Social Sciences; Humans; Male; Middle Aged; multidisciplinary; Prospective Studies; Science; Science (multidisciplinary); Stroke Volume - physiology; Ventricular Dysfunction, Right - blood; Ventricular Dysfunction, Right - complications; Ventricular Dysfunction, Right - physiopathology
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-020-73634-8

Galectin-3 is a biomarker of fibrosis, inflammation and oxidative stress, and its role in heart remodelling and exercise intolerance has not been conclusively proven in heart failure (HF) patients with reduced ejection fraction (rEF). We prospectively assessed 67 consecutive patients with symptomatic HF and left ventricular (LV) EF ≤ 35% during optimal medical therapy, with a mean serum galectin-3 concentration of 15.3 ± 6.4 and a median of 13.5 ng/mL. The group with galectin-3 concentrations greater than or equal to the median had significantly worse right ventricular (RV) systolic function parameters (s′, TAPSE), higher pulmonary artery systolic pressure, more advanced tricuspid regurgitation and lower RV-to-pulmonary circulation coupling index, while no significant differences were found in LV parameters. Moreover, this group achieved significantly lower parameters in cardiopulmonary exercise testing. Significant negative correlations were found between galectin-3 concentration and RV parameters and exercise capacity parameters and have persisted after adjustment for glomerular filtration rate, but not all of them have persisted after adjustment for NT-proBNP. Multivariate regression analysis revealed that TAPSE (β coefficient: − 0.605; p  < 0.001) and heart rate at peak exercise (β coefficient: − 0.98; p  = 0.009) were independently related to galectin-3 concentration. Elevated galectin-3 concentration in patients with HFrEF might indicate concomitant RV dysfunction and exercise intolerance.